Bois d'Artois, Bois Béni, Bois Ordinaire, Boj, Boje, Boxwood Extract, Buis, Buis Commun, Buis Toujours Vert, Bujo, Bush Tree, Buxaceae, Buxus, Buxus colchica, Buxus hyrcana, Buxus sempervirens, Dudgeon, Extrait de Buis, SPV 30.
Boxwood is a plant. People take chemicals from the leaf to make medicine (boxwood extract). The leaf itself should not be used for medicine. It can cause serious harm, including death.
Boxwood is also used for arthritis and as a “blood-detoxifying agent.”
How does it work?
Boxwood might stop viruses from reproducing, but there isn't enough scientific evidence to support this theory.
Insufficient Evidence to Rate Effectiveness for...
- Treating HIV/AIDS. There is early evidence that 990 mg per day of a specific boxwood leaf extract (SPV 30) might delay disease progression in HIV-infected people. It seems to delay decreases in CD4 cell counts, increases in viral load, and/or progression to AIDS in HIV-infected people who have no AIDS symptoms. A higher dose of 1980 mg per day does not seem to be effective.
- Stimulating the immune system.
- Detoxifying the blood.
- Other conditions.
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).
Boxwood extract (SPV 30) is POSSIBLY SAFE for most people when taken by mouth for up to 16 months. It sometimes causes diarrhea or stomach cramps.
It's LIKELY UNSAFE to use whole boxwood leaf. It has serious side effects that the leaf extract doesn't seem to have. Whole boxwood leaf can cause poisoning, including life-threatening side effects such as seizures and paralysis. It can also cause death.
Slow heart rate (bradycardia): Boxwood extract might slow down the heart rate. This could be a problem in people who already have a slow heart rate.
Gastrointestinal tract blockage: Boxwood extract might cause “congestion” in the intestines. This might cause problems in people who have a blockage in their intestines.
Ulcers: Boxwood extract might increase secretions in the stomach and intestines. There is concern that this could worsen ulcers.
Seizures: There is concern that boxwood extract might increase the risk of seizures.
Urinary tract obstruction: Boxwood extract might increase secretions in the urinary tract. There is concern that this could worsen urinary obstruction.
Drying medications (Anticholinergic drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Boxwood extract might increase levels of certain chemicals in the body that work in the brain, heart, and elsewhere. Some drying medications called "anticholinergic drugs" can also these same chemicals, but in a different way. These drying medications might decrease the effects of boxwood extract, and boxwood extract might decrease the effects of drying medications.
Medications for Alzheimer's disease (Acetylcholinesterase (AChE) inhibitors)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Boxwood extract might increase certain chemicals in the brain, heart, and elsewhere in the body. Some medications used for Alzheimer's disease also affect these chemicals. Taking boxwood extract along with medications for Alzheimer's disease might increase effects and side effects of medications used for Alzheimer's disease.
Various medications used for glaucoma, Alzheimer's disease, and other conditions (Cholinergic drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Boxwood extract might increase certain chemicals in the brain, heart, and elsewhere in the body. Some medications used for glaucoma, Alzheimer's disease, and other conditions also affect these chemicals. Taking boxwood extract with these medications might increase the chance of side effects.
The appropriate dose of boxwood depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for boxwood. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Health Solutions From Our Sponsors
Ahmed, D., Choudhary, M. I., Turkoz, S., and Sener, B. Chemical Constituents of Buxus sempervirens. Planta Med 1988;54(2):173-174. View abstract.
Ata, A., Naz, S., Choudhary, M. I., Atta, ur Rahman, Sener, B., and Turkoz, S. New triterpenoidal alkaloids from Buxus sempervirens. Z Naturforsch.[C.] 2002;57(1-2):21-28. View abstract.
Boxwood. Treat.Rev. 1995;(no 17):7. View abstract.
Dopke, W. and Muller, B. [Buxaltin and buxiramine, 2 new alkaloids from Buxus sempervirens L]. Pharmazie 1969;24(10):649. View abstract.
Durant, J., Chantre, P. H., Gonzalez, G., Vandermander, J., Halfon, P. H., Rousse, B., Guedon, D., Rahelinirina, V., Chamaret, S., Montagnier, L., and Dellamonica, P. Efficacy and safety of
Ernst, E. [How "ethics arguments" hinder research. With Buxus sempervirens against AIDS?]. Fortschr.Med. 5-20-1998;116(14):6-7. View abstract.
Gollub, M. J., Gerdes, H., and Bains, M. S. Radiographic appearances of esophageal stents. Radiographics 1997;17(5):1169-1182. View abstract.
Grodeck, B. SPV-30: where's the proof? Posit.Aware. 1995;7. View abstract.
Kuller, K. Happiness reigns in the drug marketplace. GMHC.Treat.Issues 1997;11(4/5):6-8. View abstract.
Kupchan, S. M., Kennedy, R. M., Schleigh, W. R., and Ohta, G. Buxus alkaloids. XII. Benzamide alkaloids from Buxus sempervirens L. Tetrahedron 1967;23(12):4563-4586. View abstract.
Kvaltinova, Z., Lukovic, L., Machova, J., and Fatranska, M. Effect of the steroidal alkaloid buxaminol-E on blood pressure, acetylcholinesterase activity and (3H)quinuclidinyl benzilate binding in cerebral cortex. Pharmacology 1991;43(1):20-25. View abstract.
Liu, J. P., Manheimer, E., and Yang, M. Herbal medicines for treating HIV infection and AIDS. Cochrane.Database.Syst.Rev. 2005;(3):CD003937. View abstract.
Loru, F., Duval, D., Aumelas, A., Akeb, F., Guedon, D., and Guedj, R. Four steroidal alkaloids from the leaves of Buxus sempervirens. Phytochemistry 2000;54(8):951-957. View abstract.
Orhan, I., Sener, B., Choudhary, M. I., and Khalid, A. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. J Ethnopharmacol 2004;91(1):57-60. View abstract.
Promising results for SPV-30. AIDS Patient.Care 1995;9(5):259. View abstract.
SPV-30 may offer CD4 increase. Posit.Aware. 1995;7. View abstract.
SPV-30 shows encouraging results. AIDS Patient.Care STDS. 1996;10(3):186-187. View abstract.
Stokes, D. No claims of SPV-30 success. [letter]. Posit.Aware. 1995;4. View abstract.
Tominaga, T., Guimbertau, G., and Dubourdieu, D. Contribution of benzenemethanethiol to smoky aroma of certain Vitis vinifera L. wines. J Agric.Food Chem 2-26-2003;51(5):1373-1376. View abstract.
van Neer, F. J. and van Ginkel, C. J. Allergic contact dermatitis from a boxwood recorder. Contact Dermatitis 1997;36(6):305. View abstract.
Atta-ur-Rahman Au, Ata A, Naz S, et al. New steroidal alkaloids from the roots of buxus sempervirens. J Nat Prod 1999;62:665-9. View abstract.
Durant J, Chantre P, Gonzalez G, et al. Efficacy and safety of Buxus sempervirens L. preparations (SPV30) in HIV-infected asymptomatic patients: a multicentre, randomized, double-blind, placebo-controlled trial. Phytomedicine 1998;5:1-10.